
Deepbridge Capital
Description
Deepbridge Capital is a UK-based venture capital firm and investment manager headquartered in Chester, specializing in tax-efficient investments, primarily through Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) funds. The firm focuses on identifying and supporting disruptive early-stage companies across the UK, with a particular emphasis on the technology and life sciences sectors. Their investment strategy is centered on providing growth capital to businesses with strong intellectual property and scalable business models, aiming to generate significant returns for investors while contributing to the growth of the UK's innovation economy.
Deepbridge distinguishes itself by offering a structured approach to venture capital, making it accessible to a broader range of investors through its EIS and SEIS funds. These funds pool capital from high-net-worth individuals and retail investors, which is then strategically deployed into a diversified portfolio of qualifying companies. The firm’s due diligence process is rigorous, focusing on the commercial viability of technologies, the strength of management teams, and the potential for market disruption. This systematic approach helps mitigate some of the inherent risks associated with early-stage investing, aligning with the tax-efficient nature of the schemes they operate.
Since its inception, Deepbridge Capital has demonstrated a significant commitment to the UK's innovation landscape. The firm has successfully deployed over £200 million into growth-focused technology and life sciences companies across the UK, underscoring its substantial impact on the sector. This capital has been distributed across a diverse portfolio, with Deepbridge having invested in over 40 companies to date. Typical first cheques from Deepbridge Capital into a company range from approximately $1,016,000 to $5,080,000, reflecting their role in leading or co-leading significant early-stage and growth rounds. Their ongoing support often extends beyond initial funding, providing strategic guidance to help portfolio companies scale and achieve their commercial objectives.
Investor Profile
Deepbridge Capital has backed more than 84 startups, with 4 new investments in the last 12 months alone. The firm has led 60 rounds, about 71% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Spain.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 1 rounds in the past year.
- Typical check size: $1.0M – $5.1M.
Stage Focus
- Seed (55%)
- Series Unknown (23%)
- Series A (11%)
- Pre Seed (7%)
- Series B (2%)
- Private Equity (1%)
- Corporate Round (1%)
Country Focus
- United Kingdom (93%)
- United States (2%)
- Spain (1%)
- Australia (1%)
- Singapore (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Software
- Medical Device
- Wellness
- Manufacturing
- Therapeutics
- Life Science
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.